179 related articles for article (PubMed ID: 33439364)
1. Current use of anticholinergic medications in a large naturalistic sample of psychiatric patients.
Toto S; Hefner G; Hahn M; Hiemke C; Roll SC; Wolff J; Klimke A
J Neural Transm (Vienna); 2021 Feb; 128(2):263-272. PubMed ID: 33439364
[TBL] [Abstract][Full Text] [Related]
2. Potentially inappropriate medication in older psychiatric patients.
Hefner G; Hahn M; Toto S; Hiemke C; Roll SC; Wolff J; Klimke A
Eur J Clin Pharmacol; 2021 Mar; 77(3):331-339. PubMed ID: 33029652
[TBL] [Abstract][Full Text] [Related]
3. [Anticholinergic scales: Use in psychiatry and update of the anticholinergic impregnation scale].
Javelot H; Meyer G; Becker G; Post G; Runge V; Pospieszynski P; Schneiderlin T; Armand-Branger S; Michel B; Weiner L; Faria CGF; Drapier D; Fakra E; Fossati P; Haffen E; Yrondi A; Hingray C
Encephale; 2022 Jun; 48(3):313-324. PubMed ID: 34876278
[TBL] [Abstract][Full Text] [Related]
4. [How potentially inapropriate are psychotropic drugs prescribing in acute psychiatric unit for the elderly? Results from a large multicentric audit in France].
Houix M; Humbert I; Mabileau G; Chapelet G; Sauvaget A; Gohier B; Armand-Branger S; Huon JF; D'Acremont F; Bulteau S
Geriatr Psychol Neuropsychiatr Vieil; 2023 Dec; 21(4):496-505. PubMed ID: 38269564
[TBL] [Abstract][Full Text] [Related]
5. Potentially inappropriate prescriptions of anticholinergics drugs in Alzheimer's disease patients.
Valladales-Restrepo LF; Duran-Lengua M; Machado-Alba JE
Geriatr Gerontol Int; 2019 Sep; 19(9):913-917. PubMed ID: 31342625
[TBL] [Abstract][Full Text] [Related]
6. Atropinic (anticholinergic) burden in antipsychotic-treated patients.
Montastruc F; Benevent J; Touafchia A; Chebane L; Araujo M; Guitton-Bondon E; Durrieu G; Arbus C; Schmitt L; Begaud B; Montastruc JL
Fundam Clin Pharmacol; 2018 Feb; 32(1):114-119. PubMed ID: 28887902
[TBL] [Abstract][Full Text] [Related]
7. The burden of psychotropic and anticholinergic medicines use in care homes: population-based analysis in 147 care homes.
Grill P; Marwick C; De Souza N; Burton JK; Hughes C; Guthrie B
Age Ageing; 2021 Jan; 50(1):183-189. PubMed ID: 32706851
[TBL] [Abstract][Full Text] [Related]
8. An anticholinergic burden score for German prescribers: score development.
Kiesel EK; Hopf YM; Drey M
BMC Geriatr; 2018 Oct; 18(1):239. PubMed ID: 30305048
[TBL] [Abstract][Full Text] [Related]
9. Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events.
Ness J; Hoth A; Barnett MJ; Shorr RI; Kaboli PJ
Am J Geriatr Pharmacother; 2006 Mar; 4(1):42-51. PubMed ID: 16730620
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic Drug-Drug interactions of QT-prolonging drugs in hospitalized psychiatric patients.
Hefner G; Hahn M; Hiemke C; Toto S; Wolff J; Roll SC; Klimke A
J Neural Transm (Vienna); 2021 Feb; 128(2):243-252. PubMed ID: 33417009
[TBL] [Abstract][Full Text] [Related]
11. Paying attention to pharmacokinetic and pharmacodynamic mechanisms to progress in the area of anticholinergic use in geriatric patients.
de Leon J
Curr Drug Metab; 2011 Sep; 12(7):635-46. PubMed ID: 21495973
[TBL] [Abstract][Full Text] [Related]
12. Anticholinergic burden in older inpatients on psychotropic medication: do we care?
Lee MS; Kisely S; Zolotarev B; Warren A; Henderson J; George M
Australas Psychiatry; 2017 Dec; 25(6):566-570. PubMed ID: 28868891
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced cognitive impairment in the elderly.
Moore AR; O'Keeffe ST
Drugs Aging; 1999 Jul; 15(1):15-28. PubMed ID: 10459729
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, risk factors and adverse outcomes of anticholinergic burden in patients with advanced chronic conditions at hospital admission.
Sevilla-Sánchez D; Molist-Brunet N; González-Bueno J; Solà-Bonada N; Espaulella-Panicot J; Codina-Jané C
Geriatr Gerontol Int; 2018 Aug; 18(8):1159-1165. PubMed ID: 29644803
[TBL] [Abstract][Full Text] [Related]
15. [PSYCHOTROPHIC AND ANTICHOLINERGIC DRUG BURDEN AMONG ELDERLY ISRAELI PATIENTS INVOLVED IN TRAFFIC ACCIDENTS].
Nissan R; Herskovitz A; Hirshfeld A; Stein M; Fuchs S
Harefuah; 2020 Sep; 159(9):659-665. PubMed ID: 32955808
[TBL] [Abstract][Full Text] [Related]
16. Measurement of anticholinergic effects of psychotropic drugs in humans.
Penttilä J; Scheinin H; Syvälahti E
Pharmacopsychiatry; 2005 Sep; 38(5):187-93. PubMed ID: 16189744
[TBL] [Abstract][Full Text] [Related]
17. Adverse effects of anticholinergic activity on cognitive functions in Alzheimer's disease.
Konishi K; Hori K; Uchida H; Watanabe K; Tominaga I; Kimura M; Hosoyamada M; Shibasaki T; Kataoka A; Hachisu M
Psychogeriatrics; 2010 Mar; 10(1):34-8. PubMed ID: 20594285
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and sort of pharmacokinetic drug-drug interactions in hospitalized psychiatric patients.
Hefner G; Wolff J; Hahn M; Hiemke C; Toto S; Roll SC; Messer T; Klimke A
J Neural Transm (Vienna); 2020 Aug; 127(8):1185-1198. PubMed ID: 32519194
[TBL] [Abstract][Full Text] [Related]
19. Features of anticholinergic prescriptions and predictors of high use in the elderly: Population-based study.
Joung KI; Shin JY; Cho SI
Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1591-1600. PubMed ID: 31692168
[TBL] [Abstract][Full Text] [Related]
20. Drugs with anticholinergic properties: a current perspective on use and safety.
Gerretsen P; Pollock BG
Expert Opin Drug Saf; 2011 Sep; 10(5):751-65. PubMed ID: 21635190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
